Abcam plc – LSE:ABC.L

Abcam stock price today

GBP 1,733
+507
+41.35%
Financial Health
0
1
2
3
4
5
6
7
8
9

Abcam stock price monthly change

-14.03%
month

Abcam stock price quarterly change

-9.39%
quarter

Abcam stock price yearly change

-27.07%
year

Abcam key metrics

Market Cap
 N/A
Enterprise value
 254.63B
P/E
 2.04
EV/Sales
 979.37
EV/EBITDA
 6397.93
Price/Sales
 9.78
Price/Book
 3.49
PEG ratio
 -0.02
EPS
 0.10
Revenue
 259.97M
EBITDA
 47.87M
Income
 20.62M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 4.81%
Oper. margin
 4.04%
Gross margin
 69.31%
EBIT margin
 4.04%
EBITDA margin
 18.42%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Abcam stock price history

Abcam stock forecast

Abcam financial statements

Profit Margin

Abcam plc (LSE:ABC.L): Profit margin
Jun 2019 64.97M 11.25M 17.31%
Mar 2020 65M 3.12M 4.81%
Jun 2020 65M 3.12M 4.81%
Sep 2020 65M 3.12M 4.81%
ABC.L income statement history
0%
Yield TTM
Abcam plc (LSE:ABC.L): Payout ratio
Payout ratio 0%
Abcam plc (LSE:ABC.L): Dividend Yield
2016 0.68%
2017 0.77%
2019 0.98%
2020 0.97%
2021
ABC.L dividends history

Debt to Assets

Abcam plc (LSE:ABC.L): Debt to assets
Dec 2020 822800000 193.1M 23.47%
Jun 2021 824500000 189.8M 23.02%
Dec 2021 986100000 330M 33.47%
Jun 2022 1064700000 337.1M 31.66%
ABC.L balance sheet history

Cash Flow

Abcam plc (LSE:ABC.L): Cash Flow
Jan 2020 15.75M -9.62M 14.82M
Mar 2020 15.75M -9.62M 14.82M
Jun 2020 15.75M -9.62M 14.82M
Sep 2020 15.75M -9.62M 14.82M
ABC.L cash flow history

Abcam alternative data

Abcam
Employees

Abcam plc (LSE:ABC.L): Employee count
Aug 2023 1,682
Sep 2023 1,682
Oct 2023 1,682
Nov 2023 1,682
Dec 2023 1,682
Jan 2024 1,682
Feb 2024 1,682
Mar 2024 1,682
Apr 2024 1,682
May 2024 1,682
Jun 2024 1,682
Jul 2024 1,682

Abcam other data

Abcam
Patents

Patent
Application
Filling date: 3 Aug 2018 Issue date: 4 Feb 2021
Application
Filling date: 3 Aug 2018 Issue date: 21 May 2020
Application
Filling date: 18 Dec 2017 Issue date: 21 May 2020
ABC.L patents

Abcam
Executives

Insider Compensation
Mr. Alan Thomas Hirzel BS, MS, MBA (1968) Chief Executive Officer & Executive Director
 $1,050,000
Mr. Michael Shaun Baldock (1964) Chief Financial Officer & Director
 $528,800

Frequently Asked Questions (FAQ)

  • What's the price of Abcam stock today?

    One share of Abcam stock can currently be purchased for approximately $1,733.

  • When is Abcam's next earnings date?

    Unfortunately, Abcam's (ABC.L) next earnings date is currently unknown.

  • Does Abcam pay dividends?

    No, Abcam does not pay dividends.

  • What is Abcam's stock symbol?

    Abcam plc is traded on the LSE under the ticker symbol "ABC.L".

  • What is Abcam's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Abcam?

    Shares of Abcam can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Abcam's key executives?

    Abcam's management team includes the following people:

    • Mr. Alan Thomas Hirzel BS, MS, MBA Chief Executive Officer & Executive Director(age: 57, pay: $1,050,000)
    • Mr. Michael Shaun Baldock Chief Financial Officer & Director(age: 61, pay: $528,800)

  • How many employees does Abcam have?

    As Jul 2024, Abcam employs 1,682 workers.

  • When Abcam went public?

    Abcam plc is publicly traded company for more then 19 years since IPO on 3 Nov 2005.

  • What is Abcam's official website?

    The official website for Abcam is abcam.com.

  • How can i contact Abcam?

    Abcam can be reached via phone at +44 1223 696000.

Abcam company profile:

Abcam plc

abcam.com
Exchange:

LSE

Full time employees:

1,682

Industry:

Biotechnology

Sector:

Healthcare

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

+44 1223 696000
Discovery Drive
Cambridge, CB2 0AX

:
ISIN: GB00B6774699
CUSIP: G0060R118